Literature DB >> 1730914

Presentation of antigen by mixed isotype class II molecules in normal H-2d mice.

G Ruberti1, K S Sellins, C M Hill, R N Germain, C G Fathman, A Livingstone.   

Abstract

A panel of DBA/2 T cell hybridomas specific for the sperm whale myoglobin epitope 110-121 was found to recognize antigen presented by the mixed isotype class II molecule E alpha dA beta d. The response was blocked by monoclonal antibodies specific for E alpha and A beta d chains; in addition, the hybridomas responded to antigen presented by L cells expressing E alpha A beta d molecules, and made no response with L cells expressing I-Ad or I-Ed molecules. Two more groups of hybridomas isolated from DBA/2 and B10.D2 mice immunized with myoglobin also recognized peptide 110-121 presented by E alpha d A beta d. Thus, although it is expressed at biochemically undetectable levels on spleen cells, the E alpha d A beta d molecule is an important presenting element in normal H-2d mice making a conventional immune response to a protein antigen. These results suggest that high levels of class II expression are not a prerequisite for T cell activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730914      PMCID: PMC2119090          DOI: 10.1084/jem.175.1.157

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  The presumptive CDR3 regions of both T cell receptor alpha and beta chains determine T cell specificity for myoglobin peptides.

Authors:  J S Danska; A M Livingstone; V Paragas; T Ishihara; C G Fathman
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

2.  Conformational and structural characteristics of peptides binding to HLA-DR molecules.

Authors:  C M Hill; J D Hayball; A A Allison; J B Rothbard
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

3.  Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships.

Authors:  N S Braunstein; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  Structural analysis of a peptide--HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor.

Authors:  J B Rothbard; R Busch; K Howland; V Bal; C Fenton; W R Taylor; J R Lamb
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

5.  Intracellular competition for component chains determines class II MHC cell surface phenotype.

Authors:  A J Sant; R N Germain
Journal:  Cell       Date:  1989-06-02       Impact factor: 41.582

6.  A role of Ia-associated invariant chains in antigen processing and presentation.

Authors:  B Stockinger; U Pessara; R H Lin; J Habicht; M Grez; N Koch
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

Review 7.  The class II molecules of the human and murine major histocompatibility complex.

Authors:  J F Kaufman; C Auffray; A J Korman; D A Shackelford; J Strominger
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

8.  Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules.

Authors:  L A Matis; L H Glimcher; W E Paul; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Predominant role of amino-terminal sequences in dictating efficiency of class II major histocompatibility complex alpha beta dimer expression.

Authors:  A J Sant; N S Braunstein; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  8 in total

1.  Major histocompatibility complex determinants select T-cell receptor alpha chain variable region dominance in a peptide-specific response.

Authors:  K Natarajan; D Burstyn; M Zauderer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

2.  Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II.

Authors:  C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

3.  Divergence between genes but limited allelic polymorphism in two MHC class II A genes in Leach's storm-petrels Oceanodroma leucorhoa.

Authors:  Laura M Rand; Carla Woodward; Rose May; Ross A Ackerman; Bridget Tweedie; T Bruno Zicarelli; Donald C Dearborn
Journal:  Immunogenetics       Date:  2019-09-10       Impact factor: 2.846

4.  Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.

Authors:  Kristina M Williams; Elmer C Bigley
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

5.  Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1.

Authors:  P Lane; W Gerhard; S Hubele; A Lanzavecchia; F McConnell
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

6.  T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo.

Authors:  M Fassò; N Anandasabapathy; F Crawford; J Kappler; C G Fathman; W M Ridgway
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

7.  Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

Authors:  T De Smedt; B Pajak; E Muraille; L Lespagnard; E Heinen; P De Baetselier; J Urbain; O Leo; M Moser
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

8.  A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.

Authors:  Sebastian Temme; Martin Zacharias; Jürgen Neumann; Sebastian Wohlfromm; Angelika König; Nadine Temme; Sebastian Springer; John Trowsdale; Norbert Koch
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.